VON WILLEBRAND DISEASE, TYPE 3
Clinical trials for VON WILLEBRAND DISEASE, TYPE 3 explained in plain language.
Never miss a new study
Get alerted when new VON WILLEBRAND DISEASE, TYPE 3 trials appear
Sign up with your email to follow new studies for VON WILLEBRAND DISEASE, TYPE 3, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for severe bleeding disorder: major trial tests preventive drug
Disease control Recruiting nowThis study is testing whether a medication called emicizumab can safely prevent bleeding episodes in people with a severe, rare form of von Willebrand disease (Type 3). It will compare emicizumab given as a regular preventive treatment against the current standard care, which is …
Matched conditions: VON WILLEBRAND DISEASE, TYPE 3
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Researchers track bleeding patterns in rare blood disorder patients
Knowledge-focused Recruiting nowThis study aims to gather real-world information about how well standard preventive treatment works for people with severe Type 3 Von Willebrand Disease, a rare bleeding disorder. Researchers will follow 40 patients for at least 24 weeks to track their bleeding episodes and measu…
Matched conditions: VON WILLEBRAND DISEASE, TYPE 3
Sponsor: Hoffmann-La Roche • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:41 UTC